Published in

Nature Research, Nature Communications, 1(13), 2022

DOI: 10.1038/s41467-022-30916-1

Links

Tools

Export citation

Search in Google Scholar

Identifying colorectal cancer caused by biallelic MUTYH pathogenic variants using tumor mutational signatures

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

AbstractCarriers of germline biallelic pathogenic variants in theMUTYHgene have a high risk of colorectal cancer. We test 5649 colorectal cancers to evaluate the discriminatory potential of a tumor mutational signature specific toMUTYHfor identifying biallelic carriers and classifying variants of uncertain clinical significance (VUS). Using a tumor and matched germline targeted multi-gene panel approach, our classifier identifies all biallelicMUTYHcarriers and all known non-carriers in an independent test set of 3019 colorectal cancers (accuracy = 100% (95% confidence interval 99.87–100%)). All monoallelicMUTYHcarriers are classified with the non-MUTYHcarriers. The classifier provides evidence for a pathogenic classification for two VUS and a benign classification for five VUS. Somatic hotspot mutationsKRASp.G12C andPIK3CAp.Q546K are associated with colorectal cancers from biallelicMUTYHcarriers compared with non-carriers (p = 2 × 10−23andp = 6 × 10−11, respectively). Here, we demonstrate the potential application of mutational signatures to tumor sequencing workflows to improve the identification of biallelicMUTYHcarriers.